UK & Ireland, experts provided insights on market trends within the clinical trial industry and advice on engagement ...

A panel at OCT Europe touched upon where the European clinical trial industry is headed and the impact of technology and regulations.

In a more challenging regulatory environment for clinical trials, optimising trial designs early makes success more likely.

The Declaration states that clinical trial sponsors, researchers and host country governments should ensure that all participants in clinical trials have post-trial access to treatments identified ...

Discuss the Clinical Trial Regulation implementation documents Understand the EU clinical trial authorisation process and experience Key topics to be covered include: Clinical Trials Information ...

New regulations for running clinical trials in the UK have now been signed into law. A 12-month roll-out begins 11th April to deliver the most significant update to UK clinical trials regulation in ...

Biotech and pharma organisations are calling for EU countries to harmonise regulations, or otherwise face falling behind in cutting-edge gene and cell therapy trials. The European Union has a ...

As the FDA stakes its claim as the primary regulator of AI in healthcare, it must navigate the delicate balance between fostering innovation and ensuring safety and responsibility.

The U.K. is rolling out new regulations meant to reduce red tape for clinical studies and boost the nation’s role in international trials. The law, an update of the Medicines for Human Use ...

These regulations ensure that the rights, safety and well-being of trial participants are protected and that the clinical trial data are credible and accurate (Box 1).